Literature DB >> 18030524

Chronic in-vivo experience with an endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model.

M Tarnoff1, S Shikora, A Lembo, K Gersin.   

Abstract

BACKGROUND: The role of duodenal bypass as an underlying mechanism of action in gastric bypass surgery has received considerable attention. We report the initial feasibility study of a totally endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a chronic porcine model.
METHODS: The implant consists of a 60-cm fluoropolymer sleeve that is endoscopically deployed via a coaxial catheter system into the jejunum and fixed in the proximal duodenum with a Nitinol anchor. The system creates a proximal biliopancreatic diversion. Six female Yorkshire pigs were endoscopically implanted; all survived. Four animals (group 1) were slated to survive 90 days, two animals (group 2) for 120 days, and three animals (group 3) underwent sham endoscopy and were survived 120 days. Animals were fed standard dry pig chow 0.5 kg three times daily. Data points included daily general health, weekly weight, serum blood tests (complete blood count, amylase, lipase, liver function tests), and monthly evaluation of anchor/sleeve position/patency by fluoroscopy and endoscopy. Following the in-vivo period, the devices were endoscopically removed and the animals were sacrificed. Duodenal and jejunal tissue samples were assessed histologically.
RESULTS: All six test animals were implanted and explanted without significant adverse events. In group 1, the first animal had no device-related issues. The second animal had a pivoted anchor requiring repositioning at day 63. That animal had no further difficulties. The third animal had an incidental partial rotation of the anchor noted at the 90 day explantation. The fourth animal was incidentally implanted with a crossover of the anchor struts, which was endoscopically corrected on day 14. However, on day 20 the animal had persistent vomiting, and the device was explanted. Both group 2 animals survived 120 days. One animal had a partially rotated anchor but was asymptomatic. The average weight gain between test and sham groups was 0.23 kg/day and 0.42 kg/day, respectively (p = 0.01).
CONCLUSIONS: A totally endoscopic and reversible bypass of the duodenum and proximal jejunum has been achieved for 90-120 days. Initial experience suggests patency of the sleeve and acceptable tissue response. Reduced weight gain in the test animals suggests device efficacy. Further investigation is warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030524     DOI: 10.1007/s00464-007-9652-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  6 in total

Review 1.  New developments in surgery: Natural Orifice Transluminal Endoscopic Surgery (NOTES).

Authors:  Sebastian G de la Fuente; Eric J Demaria; James D Reynolds; Dana D Portenier; Aurora D Pryor
Journal:  Arch Surg       Date:  2007-03

2.  Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study.

Authors:  Diego García-Compean; Eduardo Mendoza-Fuerte; Juan Antonio Martínez; Irma Villarreal; Héctor Maldonado
Journal:  Gastroenterol Clin Biol       Date:  2005 Aug-Sep

3.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

4.  Transoral obesity surgery: endoluminal gastroplasty with an endoscopic suture device.

Authors:  B Hu; S C Chung; L C Sun; K Kawashima; T Yamamoto; P B Cotton; C J Gostout; R H Hawes; A N Kalloo; S V Kantsevoy; P J Pasricha
Journal:  Endoscopy       Date:  2005-05       Impact factor: 10.093

Review 5.  Endoscopic treatments for obesity: past, present and future.

Authors:  Christopher J Gostout; Elizabeth Rajan
Journal:  Gastroenterol Clin North Am       Date:  2005-03       Impact factor: 3.806

6.  Endoscopic intraluminal suture plication of the gastric pouch and stoma in postoperative Roux-en-Y gastric bypass patients.

Authors:  Michael Schweitzer
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2004-08       Impact factor: 1.878

  6 in total
  9 in total

Review 1.  Development of minimally invasive techniques for management of medically-complicated obesity.

Authors:  Farzin Rashti; Ekta Gupta; Suzan Ebrahimi; Timothy R Shope; Timothy R Koch; Christopher J Gostout
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

2.  Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner.

Authors:  Eduardo Guimarães Hourneaux de Moura; Ivan Roberto Bonotto Orso; Bruno da Costa Martins; Guilherme Sauniti Lopes; Suzana Lopes de Oliveira; Manoel dos Passos Galvão-Neto; Marcio Correa Mancini; Marco Aurélio Santo; Paulo Sakai; Almino Cardoso Ramos; Arthur Belarmino Garrido-Júnior; Alfredo Halpern; Ivan Cecconello
Journal:  Obes Surg       Date:  2011-07       Impact factor: 4.129

3.  Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes.

Authors:  Charlotte de Jonge; Sander S Rensen; Hedwig M A D'Agnolo; Nicole D Bouvy; Wim A Buurman; Jan Willem M Greve
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

Review 4.  Metabolic surgery-principles and current concepts.

Authors:  M Gass; C Beglinger; R Peterli
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

5.  An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity.

Authors:  Vincent Aguirre; Nicholas Stylopoulos; Ronit Grinbaum; Lee M Kaplan
Journal:  Obesity (Silver Spring)       Date:  2008-10-30       Impact factor: 5.002

6.  Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia.

Authors:  Kirk M Habegger; Omar Al-Massadi; Kristy M Heppner; Andriy Myronovych; Jenna Holland; Jose Berger; Chun-Xia Yi; Yuanging Gao; Maarit Lehti; Nickki Ottaway; Sarah Amburgy; Christine Raver; Timo D Müller; Paul T Pfluger; Rohit Kohli; Diego Perez-Tilve; Randy J Seeley; Matthias H Tschöp
Journal:  Gut       Date:  2013-10-09       Impact factor: 23.059

Review 7.  Diabetes surgery: a new approach to an old disease.

Authors:  Francesco Rubino; Tracy-Ann Moo; Daniel J Rosen; Greg F Dakin; Alfons Pomp
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

8.  An update on less invasive and endoscopic techniques mimicking the effect of bariatric surgery.

Authors:  Froukje J Verdam; Ruben Schouten; Jan Willem Greve; Ger H Koek; Nicole D Bouvy
Journal:  J Obes       Date:  2012-08-21

9.  Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes.

Authors:  Roland E Allen; Tyler D Hughes; Jia Lerd Ng; Roberto D Ortiz; Michel Abou Ghantous; Othmane Bouhali; Philippe Froguel; Abdelilah Arredouani
Journal:  Theor Biol Med Model       Date:  2013-07-13       Impact factor: 2.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.